Investor Presentation Q1-Q3 2020 slide image

Investor Presentation Q1-Q3 2020

19 Investor presentation First nine months of 2020 Novo Nordisk corporate strategy Diabetes care Obesity care Appendix Biopharm & Other serious chronic diseases Regional information Financials Sustainability 20 32 49 59 75 108 117
View entire presentation